Heptapeptide Semax, ACTH(4-10) analog · Evidence-based safety and harm-reduction overview.
| Also known as | Heptapeptide Semax, ACTH(4-10) analog |
| Category | Nootropic |
| controlled_status | Unscheduled US (unapproved) |
| approval_status | Not FDA-approved; used clinically in Russia only |
| route | Nasal solution primarily |
| US legal status | Semax is a peptide developed in Russia and is not FDA-approved in the United States. It is sold as a research chemical and is not authorized for human consumption or medical use in the US. |
Semax is a synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH). It is used clinically in Russia for stroke and cognitive indications and is typically administered as a nasal solution.
Research suggests Semax acts by increasing BDNF (brain-derived neurotrophic factor) expression and supporting neuroprotection through multiple pathways. Studies indicate effects on GABA and dopamine signaling and possible enhancement of neuronal plasticity, though detailed mechanisms in humans remain incompletely understood.
Semax was developed at the Russian Institute of Higher Nervous Activity in the 1980s based on ACTH peptide fragments. It has been used clinically in Russia for stroke recovery, cognitive enhancement, and other CNS indications for several decades, but remains unknown in Western medicine.
Most published research on Semax comes from Russian laboratories and clinical settings, and studies report effects on BDNF expression and neuroprotection in animal and small human studies. Research suggests possible cognitive and neuroprotective effects, but rigorous, independent, large-scale human trials outside Russia are limited, leaving the evidence base mixed and incomplete.
In Russian clinical practice, Semax is typically administered nasally at doses of 250-350 micrograms once or twice daily. Nasal dosing in studies often involves sprays or drops, though volumetric accuracy from commercial products is uncertain.
This is general research/context information, not medical advice or a recommended protocol.
Semax interactions with other compounds are essentially unstudied. Any combination use should only be considered under professional medical guidance with appropriate monitoring.
If you are going to research a compound, verifying identity and purity is the single most protective step. Independent analytical testing and sterile-handling supplies reduce risk.
Compare testing optionsNo. It is not FDA-approved and is sold only as a research chemical, not for human consumption.
Most evidence is from Russian studies suggesting cognitive and neuroprotective effects, but independent large-scale human trials are lacking.
We do not provide dosing guidance. Because it is unapproved with limited safety data, consult a qualified clinician.
It is based on ACTH and shares structural similarity with some neuropeptides, but its unique effects are primarily documented in Russian research.
Primarily via nasal spray or drops in clinical Russian practice, though administration routes and dose precision vary widely in unregulated products.
Yes. Peptide formulations sold online may lack proper sterility assurance; nasal administration or injection carries infection risk without appropriate pharmaceutical manufacture.
Medical & legal disclaimer. This site is for informational and harm-reduction purposes only. It is not medical advice and is not a substitute for a licensed healthcare professional. The compounds discussed are largely not approved by the FDA for human use and many are sold strictly as research chemicals 'not for human consumption.' Nothing here is an endorsement to purchase, possess, or use any substance. Laws vary by jurisdiction. Always consult a qualified physician and follow the law where you live.
Some links on this page may be affiliate links. If you buy through them we may earn a commission at no extra cost to you. This never changes the safety information we publish.